Capivasertib
Capivasertib, sold under the brand name Truqap, is an anti-cancer medication used to treat hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer. Reference standards of Capivasertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Capivasertib
[catalogue_number] => PA 27 04652
[category_ids] => ,78,84,
[chemical_name] =>
[weight] => 428.95
[form] => C21H25ClN6O2
[cas] => 1143532-39-1
[pslug] => 1143532-39-1-capivasertib-api-standards-pa2704652
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 27 04652
Molecular Formula : C21H25ClN6O2
Molecular Weight : 428.95
stdClass Object
(
[pname] => 4-((tert-Butoxycarbonyl)amino)piperidine-4-carboxylic Acid
[catalogue_number] => PA 03 4761000
[category_ids] => ,78,84,
[chemical_name] =>
[weight] => 244.29
[form] => C11H20N2O4
[cas] => 252720-31-3
[pslug] => 252720-31-3-4-tert-butoxycarbonyl-amino-piperidine-4-carboxylic-acid-pa034761000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
4-((tert-Butoxycarbonyl)amino)piperidine-4-carboxylic Acid
Catalogue No.:PA 03 4761000
Molecular Formula : C11H20N2O4
Molecular Weight : 244.29